Literature DB >> 8928774

Chronic desensitization of the glucose-dependent insulinotropic polypeptide receptor in diabetic rats.

C C Tseng1, M O Boylan, L A Jarboe, T B Usdin, M M Wolfe.   

Abstract

Rats were rendered diabetic by streptozotocin, after which serum glucose-dependent insulinotropic polypeptide (GIP) levels, duodenal mucosal GIP content, and GIP mRNA levels were nine times, 50% and 80%, respectively, greater than in control rats. To determine whether an increase in GIP gene expression might induce chronic desensitization of its receptor, normal rats were subjected to continuous intravenous GIP infusion. Serum GIP levels increased gradually in GIP-infused rats, and by 4 h a threefold increase was detected. In response to GIP infusion, the serum insulin concentration increased at 30 min, followed by a gradual decrease, and at 4 h, no increase in insulin levels was detected despite a sustained elevated serum GIP level. The response to glucagon-like peptide-1 (GLP-1) was preserved, a reporter cell line (LGIPR2) stably transfected with rat GIP receptor cDNA was studied. GIP stimulated adenosine 3', 5'-cyclic monophosphate (cAMP) production in LGIPR2 cells, which was first detected after 1 h of stimulation, reached maximum level at 4 h, and returned to basal concentrations by 16 h. Additional stimulation with GIP at 16 h did not affect cAMP generation, indicating desensitization of the GIP receptor by the ligand. In contrast, a response to prostaglandin E1 or forskolin in GIP-desensitization was a receptor-specific process. The results of these studies indicate that GIP gene expression is enhanced in diabetic animals and that elevated serum GIP level induces chronic desensitization of the GIP receptor in vivo and in a stably transfected cell line.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8928774     DOI: 10.1152/ajpendo.1996.270.4.E661

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  13 in total

1.  A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity.

Authors:  Sameer Mohammad; Rajesh T Patel; Joanne Bruno; Muhammad Siyab Panhwar; Jennifer Wen; Timothy E McGraw
Journal:  Mol Cell Biol       Date:  2014-07-21       Impact factor: 4.272

Review 2.  The role of incretins in glucose homeostasis and diabetes treatment.

Authors:  Wook Kim; Josephine M Egan
Journal:  Pharmacol Rev       Date:  2008-12-12       Impact factor: 25.468

Review 3.  Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?

Authors:  Juris J Meier; Michael A Nauck
Journal:  Diabetes       Date:  2010-05       Impact factor: 9.461

4.  WNT/beta-catenin increases the production of incretins by entero-endocrine cells.

Authors:  J M García-Martínez; A Chocarro-Calvo; C M Moya; C García-Jiménez
Journal:  Diabetologia       Date:  2009-07-07       Impact factor: 10.122

5.  Incretin response to a standard test meal in a rat model of sleeve gastrectomy with diet-induced obesity.

Authors:  Suleiman Al-Sabah; Fahad Alasfar; Ghanim Al-Khaledi; Reshma Dinesh; Mervat Al-Saleh; Habib Abul
Journal:  Obes Surg       Date:  2014-01       Impact factor: 4.129

6.  Recent results of exenatide use as adjunctive therapy in the treatment of patients with type 2 diabetes.

Authors:  Peggy Soule Odegard; Anthony Desantis
Journal:  Diabetes Metab Syndr Obes       Date:  2009-07-31       Impact factor: 3.168

7.  Incretin responses to oral glucose load in Japanese non-obese healthy subjects.

Authors:  Etsuko Nagai; Tomoyuki Katsuno; Jun-Ichiro Miyagawa; Kosuke Konishi; Masayuki Miuchi; Fumihiro Ochi; Yoshiki Kusunoki; Masaru Tokuda; Kazuki Murai; Tomoya Hamaguchi; Mitsuyoshi Namba
Journal:  Diabetes Ther       Date:  2011-02-10       Impact factor: 2.945

8.  Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans.

Authors:  Michael A Nauck; Guido Kemmeries; Jens J Holst; Juris J Meier
Journal:  Diabetes       Date:  2011-03-23       Impact factor: 9.461

9.  Exogenous glucose-dependent insulinotropic polypeptide worsens post prandial hyperglycemia in type 2 diabetes.

Authors:  Chee W Chia; Olga D Carlson; Wook Kim; Yu-Kyong Shin; Cornelia P Charles; Hee Seung Kim; Denise L Melvin; Josephine M Egan
Journal:  Diabetes       Date:  2009-03-10       Impact factor: 9.461

10.  Effects of High Glucose Levels and Glycated Serum on GIP Responsiveness in the Pancreatic Beta Cell Line HIT-T15.

Authors:  Alessandra Puddu; Roberta Sanguineti; Fabrizio Montecucco; Giorgio Luciano Viviani
Journal:  J Diabetes Res       Date:  2015-06-29       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.